Maria do Carmo Costa1, Maria Radzwion1, Hayley S McLoughlin1, Naila S Ashraf1, Svetlana Fischer1, Vikram G Shakkottai1,2, Patrícia Maciel3, Henry L Paulson1, Gülin Öz4. 1. Department of Neurology, University of Michigan, Ann Arbor, Michigan, USA. 2. Department of Molecular & Integrative Physiology, University of Michigan, Ann Arbor, Michigan, USA. 3. Life and Health Sciences Research Institute, School of Health Sciences, University of Minho, Braga, Portugal. 4. Center for Magnetic Resonance Research, Department of Radiology, Medical School, University of Minnesota, Minneapolis, Minnesota, USA.
Abstract
BACKGROUND: No treatment exists for the most common dominantly inherited ataxia Machado-Joseph disease, or spinocerebellar ataxia type 3 (SCA3). Successful evaluation of candidate therapeutics will be facilitated by validated noninvasive biomarkers of disease pathology recapitulated by animal models. OBJECTIVE: We sought to identify shared in vivo neurochemical signatures in two mouse models of SCA3 that reflect the human disease pathology. METHODS: Cerebellar neurochemical concentrations in homozygous YACMJD84.2 (Q84/Q84) and hemizygous CMVMJD135 (Q135) mice were measured by in vivo magnetic resonance spectroscopy at 9.4 tesla. To validate the neurochemical biomarkers, levels of neurofilament medium (NFL; indicator of neuroaxonal integrity) and myelin basic protein (MBP; indicator of myelination) were measured in cerebellar lysates from a subset of mice and patients with SCA3. Finally, NFL and MBP levels were measured in the cerebellar extracts of Q84/Q84 mice upon silencing of the mutant ATXN3 gene. RESULTS: Both Q84/Q84 and Q135 mice displayed lower N-acetylaspartate than wild-type littermates, indicating neuroaxonal loss/dysfunction, and lower myo-inositol and total choline, indicating disturbances in phospholipid membrane metabolism and demyelination. Cerebellar NFL and MBP levels were accordingly lower in both models as well as in the cerebellar cortex of patients with SCA3 than controls. Importantly, N-acetylaspartate and total choline correlated with NFL and MPB, respectively, in Q135 mice. Long-term sustained RNA interference (RNAi)-mediated reduction of ATXN3 levels increased NFL and MBP in Q84/Q84 cerebella. CONCLUSIONS: N-acetylaspartate, myo-inositol, and total choline levels in the cerebellum are candidate biomarkers of neuroaxonal and oligodendrocyte pathology in SCA3, aspects of pathology that are reversible by RNAi therapy.
BACKGROUND: No treatment exists for the most common dominantly inherited ataxia Machado-Joseph disease, or spinocerebellar ataxia type 3 (SCA3). Successful evaluation of candidate therapeutics will be facilitated by validated noninvasive biomarkers of disease pathology recapitulated by animal models. OBJECTIVE: We sought to identify shared in vivo neurochemical signatures in two mouse models of SCA3 that reflect the human disease pathology. METHODS: Cerebellar neurochemical concentrations in homozygous YACMJD84.2 (Q84/Q84) and hemizygous CMVMJD135 (Q135) mice were measured by in vivo magnetic resonance spectroscopy at 9.4 tesla. To validate the neurochemical biomarkers, levels of neurofilament medium (NFL; indicator of neuroaxonal integrity) and myelin basic protein (MBP; indicator of myelination) were measured in cerebellar lysates from a subset of mice and patients with SCA3. Finally, NFL and MBP levels were measured in the cerebellar extracts of Q84/Q84 mice upon silencing of the mutant ATXN3 gene. RESULTS: Both Q84/Q84 and Q135 mice displayed lower N-acetylaspartate than wild-type littermates, indicating neuroaxonal loss/dysfunction, and lower myo-inositol and total choline, indicating disturbances in phospholipid membrane metabolism and demyelination. Cerebellar NFL and MBP levels were accordingly lower in both models as well as in the cerebellar cortex of patients with SCA3 than controls. Importantly, N-acetylaspartate and total choline correlated with NFL and MPB, respectively, in Q135 mice. Long-term sustained RNA interference (RNAi)-mediated reduction of ATXN3 levels increased NFL and MBP in Q84/Q84 cerebella. CONCLUSIONS:N-acetylaspartate, myo-inositol, and total choline levels in the cerebellum are candidate biomarkers of neuroaxonal and oligodendrocyte pathology in SCA3, aspects of pathology that are reversible by RNAi therapy.
Authors: James M Joers; Dinesh K Deelchand; Tianmeng Lyu; Uzay E Emir; Diane Hutter; Christopher M Gomez; Khalaf O Bushara; Lynn E Eberly; Gülin Öz Journal: Ann Neurol Date: 2018-04-10 Impact factor: 10.422
Authors: Y Kawaguchi; T Okamoto; M Taniwaki; M Aizawa; M Inoue; S Katayama; H Kawakami; S Nakamura; M Nishimura; I Akiguchi Journal: Nat Genet Date: 1994-11 Impact factor: 38.330
Authors: Jillian Friedrich; Holly B Kordasiewicz; Brennon O'Callaghan; Hillary P Handler; Carmen Wagener; Lisa Duvick; Eric E Swayze; Orion Rainwater; Bente Hofstra; Michael Benneyworth; Tessa Nichols-Meade; Praseuth Yang; Zhao Chen; Judit Perez Ortiz; H Brent Clark; Gülin Öz; Sarah Larson; Huda Y Zoghbi; Christine Henzler; Harry T Orr Journal: JCI Insight Date: 2018-11-02
Authors: Kristen H Schuster; Annie J Zalon; Hongjiu Zhang; Danielle M DiFranco; Nicholas R Stec; Zaid Haque; Kate G Blumenstein; Amanda M Pierce; Yuanfang Guan; Henry L Paulson; Hayley S McLoughlin Journal: J Neurosci Date: 2022-01-18 Impact factor: 6.709
Authors: Eva Haas; Rana D Incebacak; Thomas Hentrich; Chrisovalantou Huridou; Thorsten Schmidt; Nicolas Casadei; Yacine Maringer; Carola Bahl; Frank Zimmermann; James D Mills; Eleonora Aronica; Olaf Riess; Julia M Schulze-Hentrich; Jeannette Hübener-Schmid Journal: Mol Neurobiol Date: 2021-10-30 Impact factor: 5.682
Authors: Karen Jansen-West; Tiffany W Todd; Lillian M Daughrity; Mei Yue; Jimei Tong; Yari Carlomagno; Giulia Del Rosso; Aishe Kurti; Caroline Y Jones; Judith A Dunmore; Monica Castanedes-Casey; Dennis W Dickson; Zbigniew K Wszolek; John D Fryer; Leonard Petrucelli; Mercedes Prudencio Journal: Front Cell Dev Biol Date: 2022-03-21
Authors: David D Bushart; Annie J Zalon; Hongjiu Zhang; Logan M Morrison; Yuanfang Guan; Henry L Paulson; Vikram G Shakkottai; Hayley S McLoughlin Journal: Cerebellum Date: 2021-02 Impact factor: 3.847